CE: Examining Hemophilia Treatments: Updates for Specialty Pharmacists

Specialty Pharmacy Times, October 2020, Volume 3, Issue 3

This activity is supported by an educational grant from Biomarin Pharmaceuticals, Inc.

This activity is supported by an educational grant from Biomarin Pharmaceuticals, Inc.

EDUCATIONAL OBJECTIVES

At the completion of this activity, the participant will be able to:

• Examine the impact of treatments and therapies for hemophilia, including effects on patient quality

of life

• Explore and utilize clinical data for emerging hemophilia therapies to help guide treatment

decisions

• Identify therapeutic differences of available treatments in the management of hemophilia

FACULTY

Justin Arnall, PharmD, BCOP

Pharmacist Clinical Coordinator, Hematology

Specialty Pharmacy Services, Department of Pharmacy, Atrium Health; Charlotte, North Carolina

TARGET AUDIENCE: Pharmacists

ACTIVITY TYPE: Application

RELEASE DATE: October 15, 2020

EXPIRATION DATE: October 15, 2021

ESTIMATED TIME TO COMPLETE ACTIVITY: 2.0 hours

FEE: This lesson is offered for free at www.pharmacytimes.org.